OA3 HOW DO PRESCRIBERS ACT WHEN A PRODUCT IS WITHDRAWN FROM THE MARKET? FIRST LESSONS FROM THE COX-2 INHIBITORS PATIENTS POST ROFECOXIB STUDY (CIPRES)
Abstract
Authors
C Le Pen JF Bergmann M Dougados P Ruszniewski D Umuhire C Chen P Kramarz H Lilliu